Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2025)

Revolution Medicines has reported Other Non Operating Income over the past 2 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $1.3 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.6 million (changed N/A YoY), and the annual figure for FY2025 was $1.3 million, changed.
  • Other Non Operating Income for Q4 2025 was $1.3 million at Revolution Medicines, up from -$10000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for RVMD hit a ceiling of $1.3 million in Q4 2025 and a floor of -$2.8 million in Q1 2024.